A dual-targeted multifunctional nanoformulation for potential prevention and therapy of Alzheimer's disease

Antioxidation and adjustable treatment strategies are critical for the effective treatment of Alzheimer's disease (AD). Here, we design a dual-targeted Prussian blue nanoformulation (PTCN) that can cross the blood-brain barrier and target amyloid beta aggregates further exert antioxidant effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Dongju, Tang, Yuqing, Suo, Xinjun, Zhang, Chaonan, Dou, Yan, Chang, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640585/
https://www.ncbi.nlm.nih.gov/pubmed/34901904
http://dx.doi.org/10.1016/j.xinn.2021.100160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640585/
https://www.ncbi.nlm.nih.gov/pubmed/34901904
http://dx.doi.org/10.1016/j.xinn.2021.100160

Ejemplares similares